Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GS +3.4%, MTB +2.7%
Other news:
- SNPO +30.3% (Snap One to be acquired by Resideo (REZI) for $10.75 per share)
- PLL +22.8% (Receives mining permit approval for Carolina Lithium)
- WIRE +7.7% (to be acquired for $290.00 per share in cash by Prysmian)
- TELA +5.5% (Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR -- Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures)
- REZI +5.1% (Snap One to be acquired by Resideo (REZI) for $10.75 per share)
- ROAD +4.7% (announces $40 mln share repurchase authorization)
- AA +4.2% (United States and United Kingdom take action to reduce Russian revenue from metals)
- APG +3.3% (acquires Elevated Facility Services Group for $570 mln in cash)
- BLKB +2.7% (Clearlake Capital Group confirms proposal to acquire all of the outstanding shares of Common Stock for a price of $80.00 per share in cash)
- AQST +2.3% (to Present Crossover Study Data for Libervant (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology)
- NVAX +2.3% (Shah Capital nominates two highly qualified independent director candidates for Novavax)
- NOK +2.1% (Nokia and SURF reach 800Gb/s transmission on existing fiber to prepare for massive upgrade to CERN's Large Hadron Collider)
- LSXMA +1.9% (Warren Buffett of Berkshire Hathaway (BRK.A) disclosed the purchase of LXSMA and LSXMK shares (transaction dates 4/10-4/12))
- OCUL +1.9% (Executive Chairman Pravin Dugel, MD becomes President and CEO Antony Mattessich is stepping down as President and CEO)
- SNY +1.6% (Innate Pharma Announces Advancement of Sanofi (SNY)-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients)
- NYCB +1.1% (names Craig Gifford as CFO)